Medical management of acute intracerebral hemorrhage
- PMID: 19578319
- DOI: 10.1097/MCC.0b013e328325d12c
Medical management of acute intracerebral hemorrhage
Abstract
Purpose of review: Intracerebral hemorrhage (ICH) is the most serious but least treatable form of stroke, with prognosis critically dependent on both the size and degree of hematoma expansion. Treatments that target hematoma expansion offer potential to improve outcomes. This review analyzes the recent literature pertaining to the medical management of ICH.
Recent findings: Modern imaging studies have confirmed the dynamic nature of ICH. At least one-third of patients experience significant continued bleeding and hematoma expansion in the first few hours after onset, more so in warfarin-related ICH. Despite a strong biological rationale for benefit, a large clinical trial of recombinant activated factor VII failed to show any treatment effects on substantive outcomes despite clear attenuation of hematoma growth. The impact of recombinant activated factor VII is therefore severely restricted because of uncertain efficacy, definite hazard, and high cost. Accumulating evidence indicates beneficial effects from the early normalization of international normalized ratio levels and replacement of coagulation factors in warfarin-related ICH. Although high blood pressure (BP) is common and associated with poor outcomes in ICH, there is insufficient evidence to recommend a specific early BP management strategy, although recent randomized evidence indicates that such treatment is well tolerated and readily incorporated into routine clinical practice. Definitive evidence to support a low-cost, widely applicable treatment is urgently required for a condition in which therapy is primarily supportive.
Summary: In patients with acute ICH, rapid intensive BP-lowering treatment may provide protection against hematoma growth without concerns about safety and tolerability. How well such treatment can translate into overall benefits to patients is yet to be determined. At present, recombinant activated factor VII cannot be recommended for routine use, although BP lowering should generally follow conservative guidelines.
Similar articles
-
Reducing the risk of ICH enlargement.J Neurol Sci. 2007 Oct 15;261(1-2):99-107. doi: 10.1016/j.jns.2007.04.044. Epub 2007 Jul 12. J Neurol Sci. 2007. PMID: 17631908 Review.
-
Dynamics of intraventricular hemorrhage in patients with spontaneous intracerebral hemorrhage: risk factors, clinical impact, and effect of hemostatic therapy with recombinant activated factor VII.Neurosurgery. 2006 Oct;59(4):767-73; discussion 773-4. doi: 10.1227/01.NEU.0000232837.34992.32. Neurosurgery. 2006. PMID: 17038942 Clinical Trial.
-
Blood pressure in acute intracerebral haemorrhage.J Hum Hypertens. 2004 Mar;18(3):187-92. doi: 10.1038/sj.jhh.1001647. J Hum Hypertens. 2004. PMID: 14973513 Review.
-
Ultra-early hemostatic therapy for primary intracerebral hemorrhage: a review.Can J Neurol Sci. 2005 Dec;32 Suppl 2:S31-7. Can J Neurol Sci. 2005. PMID: 16450806 Review.
-
[Acute treatment with recombinant factor VII is probably indicated for intracerebral haematoma].Ned Tijdschr Geneeskd. 2005 Aug 13;149(33):1827-9. Ned Tijdschr Geneeskd. 2005. PMID: 16128178 Dutch.
Cited by
-
Brain imaging in stroke: insight beyond diagnosis.Neurotherapeutics. 2011 Jul;8(3):330-9. doi: 10.1007/s13311-011-0046-0. Neurotherapeutics. 2011. PMID: 21556679 Free PMC article. Review.
-
Advances in neuroprotective strategies: potential therapies for intracerebral hemorrhage.Cerebrovasc Dis. 2011;31(3):211-22. doi: 10.1159/000321870. Epub 2010 Dec 21. Cerebrovasc Dis. 2011. PMID: 21178344 Free PMC article. Review.
-
Effects of timing of dexamethasone treatment on the outcome of collagenase-induced intracerebral hematoma in rats.Comp Med. 2009 Oct;59(5):444-8. Comp Med. 2009. PMID: 19887028 Free PMC article.
-
After Intracerebral Hemorrhage, Oligodendrocyte Precursors Proliferate and Differentiate Inside White-Matter Tracts in the Rat Striatum.Transl Stroke Res. 2016 Jun;7(3):192-208. doi: 10.1007/s12975-015-0445-3. Epub 2016 Jan 8. Transl Stroke Res. 2016. PMID: 26743212 Free PMC article.
-
ACE variants and association with brain Aβ levels in Alzheimer's disease.Am J Transl Res. 2010 Oct 15;3(1):73-80. Am J Transl Res. 2010. PMID: 21139807 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials